Bristol-Myers Up Big After Drug Study Stopped Early

By: via Benzinga
Bristol-Myers Squibb Co (NYSE: BMY)was more than 3 percent higher in early trading after the company announced that Phase III ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.